Indefinite Delivery Contract SPE2DP20D0002
Award Date 2/3/20
Last Date to Order 12/31/29
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Teva Pharmaceuticals USA, Inc. holds a multiple-award Federal Supply Schedule (FSS) contract for pharmaceutical and hematology-related products (FSS-61-IB) awarded by the Veterans Integrated Service Network 12 on August 15, 2017, with a ceiling value of $3.6 billion and an ultimate completion date of April 30, 2026. As a no-set-aside procurement, this indefinite delivery contract establishes Teva as a supplier of drugs, pharmaceuticals, and hematology-related products to support federal...
- Teva Pharmaceuticals USA, Inc. was awarded a single-award Indefinite Delivery Contract valued at $64.4 million by the Department of Veterans Affairs National Acquisition Center on August 5, 2023, to supply glatiramer acetate injections to federal healthcare programs. The contract establishes a base ordering period from August 5, 2023, through August 4, 2024, with four one-year renewal options extending through August 4, 2026. The procurement addresses estimated annual requirements exceeding...
- Teva Pharmaceuticals USA, Inc. was awarded a single-award Indefinite Delivery Contract valued at $5.69 million by the Defense Logistics Agency (DLA) Troop Support Medical, effective August 31, 2022, through August 30, 2027. This contract establishes Teva as the national prime vendor for Levalbuterol HCL Solution, a bronchodilator medication used in respiratory treatment. The contract encompasses a no-set-aside procurement and was preceded by a pre-solicitation notice posted on September 30,...
- This Indefinite Delivery Contract was awarded by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense, to the prime contractor Pfizer Inc., a large pharmaceutical manufacturer. The contract has a ceiling value of $48,683,160.88 and a period of performance through August 31, 2030. It does not utilize any small business set-asides. The contract primarily aims to procure a wide range of pharmaceutical products and medical supplies for the Department of...
- This single-award Indefinite Delivery Contract, valued at $46.9 million and awarded to Pfizer Inc. on August 13, 2025, establishes a prime vendor agreement for the supply of Bevacizumab injections to support multiple federal healthcare organizations including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract is administered by the National Acquisition Center and covers a base ordering period from...
- Hikma Pharmaceuticals USA Inc., doing business as FKA West-Ward Pharmaceuticals, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency's Medical Supply Chain on July 14, 2020, with a ceiling value of $42,907,335.98 and an ultimate completion date of July 14, 2030. The contract establishes an indefinite delivery vehicle for the manufacture and distribution of pharmaceutical products to support Department of Defense medical supply requirements. No small business...
- Takeda Pharmaceuticals America, Inc., a foreign-owned subsidiary based in Cambridge, Massachusetts, was awarded a multiple-award Federal Supply Schedule contract (FSS-61-IB) for Drugs, Pharmaceuticals, and Hematology-Related Products by Veterans Integrated Service Network 12, effective September 15, 2025, through September 28, 2030. The contract carries a ceiling value of approximately $2.89 billion with no small business set-aside designation. This indefinite delivery vehicle serves as a...
- Valneva USA, Inc., a subsidiary of French vaccine manufacturer Valneva SE, was awarded a single-award Indefinite Delivery Contract valued at $49.3 million by the Defense Logistics Agency Troop Support Medical on behalf of the Department of Defense's Medical Supply Chain division. The contract, which commenced January 29, 2025, and extends through January 28, 2026, establishes a vehicle for the supply of the Japanese encephalitis vaccine IXIARO to support Department of Defense medical...
- Pfizer Inc. was awarded a multiple-award Federal Supply Schedule contract valued at $7.31 billion by the Department of Veterans Affairs' Veterans Integrated Service Network 12 on July 1, 2024, with a performance period extending through June 30, 2029. This indefinite delivery vehicle covers pharmaceutical and hematology-related products under Federal Supply Schedule 65 I B, with no small business set-aside applied. The contract establishes Pfizer as a prime vendor for critical pharmaceutical...
- This indefinite delivery contract, awarded by the Defense Logistics Agency Troop Support Medical, provides for the delivery of various medical products and treatments to the U.S. government. The prime contractor is Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. The contract, valued at up to $597 million, has a period of performance from January 1, 2013 to December 31, 2014. It does not utilize any set-aside designations. Meridian has been awarded multiple delivery...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order SPE2DP20D0002-SPE2DP23F4569 | Teva Pharmaceuticals Usa, Inc. | $610.8k | 6/20/23 | 6/27/23 | 6/20/23 | |
Delivery Order SPE2DP20D0002-SPE2DP21F2287 | Teva Pharmaceuticals Usa, Inc. | $141.2k | 2/22/21 | 2/23/21 | 2/22/21 | |
Delivery Order SPE2DP20D0002-SPE2DP21F0373 | Teva Pharmaceuticals Usa, Inc. | $271.5k | 11/3/20 | 11/17/20 | 11/3/20 | |
Delivery Order SPE2DP20D0002-SPE2DP23F6109 | Teva Pharmaceuticals Usa, Inc. | $610.8k | 9/12/23 | 9/19/23 | 9/12/23 | |
Delivery Order SPE2DP20D0002-SPE2DP24F6268 | Teva Pharmaceuticals Usa, Inc. | $317.6k | 7/19/24 | 7/30/24 | 7/19/24 |